MetaVia, Inc. (MTVA)
1.29
+0.06
(+4.88%)
USD |
NASDAQ |
Oct 20, 16:00
1.27
-0.02
(-1.55%)
After-Hours: 05:46
MetaVia Price : 1.29 for Oct. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 1.26 | 1.32 | 1.20 | 1.29 | 22099.00 |
| Oct 19, 2026 | 1.29 | 1.32 | 1.225 | 1.23 | 54277.00 |
| Oct 16, 2026 | 1.38 | 1.43 | 1.26 | 1.26 | 75916.00 |
| Oct 15, 2026 | 1.35 | 1.44 | 1.325 | 1.37 | 50284.00 |
| Oct 14, 2026 | 1.40 | 1.435 | 1.350 | 1.36 | 40627.00 |
| Oct 13, 2026 | 1.52 | 1.52 | 1.415 | 1.43 | 65682.00 |
| Oct 12, 2026 | 1.43 | 1.589 | 1.41 | 1.45 | 137240.0 |
| Oct 09, 2026 | 1.35 | 1.44 | 1.35 | 1.41 | 51049.00 |
| Oct 08, 2026 | 1.47 | 1.48 | 1.33 | 1.34 | 113983.0 |
| Oct 07, 2026 | 1.47 | 1.52 | 1.46 | 1.46 | 30837.00 |
| Oct 06, 2026 | 1.52 | 1.54 | 1.45 | 1.48 | 86792.00 |
| Oct 05, 2026 | 1.55 | 1.587 | 1.54 | 1.54 | 53613.00 |
| Oct 02, 2026 | 1.56 | 1.65 | 1.51 | 1.54 | 64263.00 |
| Oct 01, 2026 | 1.59 | 1.605 | 1.52 | 1.54 | 47052.00 |
| Sep 30, 2026 | 1.64 | 1.66 | 1.55 | 1.57 | 65620.00 |
| Sep 29, 2026 | 1.64 | 1.67 | 1.61 | 1.66 | 26072.00 |
| Sep 28, 2026 | 1.65 | 1.70 | 1.62 | 1.67 | 134994.0 |
| Sep 25, 2026 | 1.68 | 1.68 | 1.61 | 1.66 | 28750.00 |
| Sep 24, 2026 | 1.662 | 1.662 | 1.61 | 1.63 | 65332.00 |
| Sep 23, 2026 | 1.65 | 1.665 | 1.61 | 1.63 | 38442.00 |
| Sep 22, 2026 | 1.69 | 1.69 | 1.64 | 1.68 | 31611.00 |
| Sep 21, 2026 | 1.65 | 1.701 | 1.64 | 1.67 | 45290.00 |
| Sep 18, 2026 | 1.55 | 1.73 | 1.55 | 1.73 | 108681.0 |
| Sep 17, 2026 | 1.550 | 1.59 | 1.52 | 1.59 | 39252.00 |
| Sep 16, 2026 | 1.570 | 1.590 | 1.52 | 1.54 | 46273.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.44 |
| Alnylam Pharmaceuticals, Inc. | 230.71 |
| Anika Therapeutics, Inc. | 20.44 |
| Savara, Inc. | 4.76 |
| Vericel Corp. | 40.58 |
Price Related Metrics
| Price to Book Value | 1.243 |
| Earnings Yield | -313.2% |
| Market Cap | 8.483M |